5003 ORAL A randomised phase II study of carboplatin plus liposomal doxorubicin (CLD) vs carboplatin plus paclitaxel (CP) in potentially platinum sensitive ovarian cancer patients. A Hellenic Cooperative Oncology Group study

✍ Scribed by Linardou, H.; Bafaloukos, D.; Bamias, A.; Xanthakis, I.; Kalofonos, H.P.; Aravantinos, G.; Kosmidis, P.; Briasoulis, E.; Klouvas, G.; Dimopoulos, A.M.

• Book ID: 122932531
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 59 KB
• Volume: 5
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/S1359-6349(07)71175-8